A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
Artificial intelligence can now make discoveries 10 times faster than humans. But if people can’t understand those ...
An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease.
Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...
The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...
As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company's efforts. The European Commission pledged a 35 million ...
Moderna (MRNA) has drawn attention after its stock climbed around 12% over the past week. Investors are weighing the company’s recent financial results, as annual revenue shows about 20% growth and ...
Given the labyrinth of patent litigation ongoing between companies that were working on mRNA vaccines during the pandemic, a merger agreement between two of them – BioNTech and CureVac – raised ...
On October 25, 2025, the author and game-show host Ken Jennings joined the senior editor Tyler Foggatt onstage at the 26th ...
Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results